Haleon plc (HLNCF)
| Previous close | 4.1050 |
| Open | 4.0480 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 4.0480 - 4.0860 |
| 52-week range | 3.8100 - 4.3550 |
| Volume | |
| Avg. volume | 41,121 |
| Market cap | 37.42B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 27.24 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.08 (1.84%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- PR Newswire
Abreva Drops One-of-a-Kind Pair of Diamond Lips, Inspired by the Cold Sore Experience
Abreva is encouraging consumers to rock their cold sores with confidence, unveiling a highly covetable, one-of-a-kind pair of diamond lips. The bejeweled piece is fashioned to destigmatize a condition that many are ashamed to discuss, let alone flaunt. In fact, 2/3 of young cold sore sufferers say their self-esteem and confidence is shaken when a cold sore strikes1.
- PR Newswire
Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon
Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (LSE / NYSE: HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals.
- PR Newswire
New Research Affirms the Positive Impact of Centrum Silver on Memory in Older Adults
New study results from the COSMOS trial offers additional evidence regarding the benefit of Centrum Silver multivitamins on cognitive health in older adults. The third independent cognition trial to measure cognitive function and memory in older adults echoed previous findings of COSMOS-Mind and COSMOS-Web which all indicate that daily use of Centrum Silver versus placebo resulted in significant improvements in performance on tests measuring memory.
